Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Diabetes PHGKB

Specific PHGKB|Diabetes PHGKB|Public Health Genomics and Precision Health Knowledge Base (PHGKB)
Effective August 1, 2024, this database will be discontinued. All content will remain searchable and be preserved online for historical purposes only until 2029.

Last Posted: Jul 25, 2024
spot light Spotlight

Prediction of progression to type 1 diabetes with dynamic biomarkers and risk scores
(Posted May 26, 2024 11AM)

From the abstract: "Identifying biomarkers of functional ß-cell loss is an important step in the risk stratification of type 1 diabetes. Genetic risk scores (GRS), generated by profiling an array of single nucleotide polymorphisms, are a widely used type 1 diabetes risk-prediction tool. Type 1 diabetes screening studies have relied on a combination of biochemical (autoantibody) and GRS screening methodologies for identifying individuals at high-risk of type 1 diabetes. "

Equitable implementation of a precision digital health program for glucose management in individuals with newly diagnosed type 1 diabetes
(Posted May 03, 2024 5PM)

From the abstract: " Few young people with type 1 diabetes (T1D) meet glucose targets. Continuous glucose monitoring improves glycemia, but access is not equitable. We prospectively assessed the impact of a systematic and equitable digital-health-team-based care program implementing tighter glucose targets (HbA1c?<?7%), early technology use (continuous glucose monitoring starts <1?month after diagnosis) and remote patient monitoring on glycemia in young people with newly diagnosed T1D enrolled in the Teamwork, Targets, Technology, and Tight Control (4T Study)."

Polygenic scores for longitudinal prediction of incident type 2 diabetes in an ancestrally and medically diverse primary care physician network: a patient cohort study
(Posted Apr 29, 2024 11AM)

From the article: "Genetic information, if available, could improve T2D prediction among patients lacking measured clinical risk factors. Genome-wide association studies (GWAS) have identified hundreds of unique loci associated with T2D, the results of which can be used to calculate polygenic scores (PGS) that model genetic risk independently of established clinical risk factors including family history. Previous work has evaluated how PGS can be used within healthcare systems, but analyses have been largely cross-sectional in biobanks of mostly European ancestry, limiting the generalizability of results to a more ancestrally and medically diverse US healthcare system. "

Multi-ancestry polygenic mechanisms of type 2 diabetes
K Smith et al, Nature Medicine, March 6, 2024 (Posted Mar 06, 2024 9AM)

From the abstract: "Type 2 diabetes (T2D) is a multifactorial disease with substantial genetic risk, for which the underlying biological mechanisms are not fully understood. In this study, we identified multi-ancestry T2D genetic clusters by analyzing genetic data from diverse populations in 37 published T2D genome-wide association studies representing more than 1.4 million individuals. We implemented soft clustering with 650 T2D-associated genetic variants and 110 T2D-related traits, capturing known and novel T2D clusters with distinct cardiometabolic trait associations across two independent biobanks. "


news Latest News and Publications
AI Hesitancy and Acceptability-Perceptions of AI Chatbots for Chronic Health Management and Long COVID Support: Survey Study. External Web Site Icon
Wu Philip Fei, et al. JMIR human factors 2024 0 0. e51086
BARIATRIC SURGERIES IN THE BRAZILIAN PUBLIC HEALTH SYSTEM FROM 2012 TO 2022: DESCRIPTIVE STUDY OF HOSPITALIZATIONS IN THE STATE OF PARANÁ. External Web Site Icon
Fahs Hassan Ali, et al. Arquivos de gastroenterologia 2024 0 0. e24009
Anxiety symptoms and risk factors in patients with SARS-cov-2 omicron variant in shanghai, China. External Web Site Icon
Chen Qing, et al. International journal of psychiatry in medicine 2024 0 0. 912174241264671
Impact of diabetes on COVID-19 and glucocorticoids on patients with COVID-19 and diabetes during the Omicron variant epidemic: a multicenter retrospective cohort study in South China. External Web Site Icon
Xu Yonghao, et al. BMC infectious diseases 2024 0 0. (1) 706
At-admission prediction of mortality and pulmonary embolism in an international cohort of hospitalised patients with COVID-19 using statistical and machine learning methods. External Web Site Icon
Mesinovic Munib, et al. Scientific reports 2024 0 0. (1) 16387
Data-independent LC-MS/MS analysis of ME/CFS plasma reveals a dysregulated coagulation system, endothelial dysfunction, downregulation of complement machinery. External Web Site Icon
Nunes Massimo, et al. Cardiovascular diabetology 2024 0 0. (1) 254
Identification of risk factors of Long COVID and predictive modeling in the RECOVER EHR cohorts. External Web Site Icon
Zang Chengxi, et al. Communications medicine 2024 0 0. (1) 130
Effects of genetic risk on incident type 2 diabetes and glycemia: the T2D-GENE lifestyle intervention trial. External Web Site Icon
Maria Anneli Lankinen et al. J Clin Endocrinol Metab 2024
Precision symptom phenotyping identifies early clinical and proteomic predictors of distinct COVID-19 sequelae. External Web Site Icon
Epsi Nusrat J, et al. The Journal of infectious diseases 2024 0 0.
A unified framework for estimating country-specific cumulative incidence for 18 diseases stratified by polygenic risk. External Web Site Icon
Bradley Jermy et al. Nat Commun 2024 15(1) 5007

More

About Diabetes PHGKB

Diabetes PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that address the translation of genomic and other precision health discoveries into improved health care and prevention related to diabetes...more

Content Summary

Common Diabetes Related Topics

Quick Links


Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.

TOP